← 產業報告目錄
Virtual Clinical Trials Market Size, Share & Trends Analysis Report By business Mode of Clinical Trial (Hybrid Clinical Trial and Fully Virtual Clinical Trial), Study Type (Interventional, Observational, Expanded Access), Type Of Therapeutic Area, Clinical Trial Phase, Company Size, End-User, Region And Segment Forecasts, 2023-2031
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-02-01頁數 180報告編號 INSIGHTACE-c06a41752b
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
The Virtual Clinical Trials Market on a global scale was estimated at USD 14.8 billion in 2023 and is set to attain USD 26.3 billion by 2031, with a projected CAGR of 7.6% between 2024 and 2031.
The Virtual Clinical Trials sector involves those trials that are executed through telemedicine and local mobile healthcare providers, using procedures and technologies that differ from the conventional clinical tria. This domain has witnessed meaningful transformation owing to technological breakthroughs and shifting healthcare dynamics.
Growth is bolstered by a convergence of factors: rising awareness among end users, continuous product innovation, and the rising emphasis on efficiency and sustainability within the healthcare sector.
Segmental analysis reveals differentiated growth across product categories, applications, and geographical regions, with certain niches demonstrating above-average expansion potential.
Regional dynamics show North America and Europe as established hubs, with the Asia-Pacific region set to deliver the strongest growth trajectory through the forecast period, bolstered by demographic shifts and policy support.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Virtual Clinical Trials Market Snapshot
Chapter 4. Global Virtual Clinical Trials Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Mode of Clinical Trial Estimates & Trend Analysis
5.1. by Mode of Clinical Trial & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Mode of Clinical Trial:
5.2.1. Hybrid Clinical Trials
5.2.2. Fully Virtual Clinical Trials
Chapter 6. Market Segmentation 2: by Study Type Estimates & Trend Analysis
6.1. by Study Type & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Study Type:
6.2.1. Interventional
6.2.2. Observational
6.2.3. Expanded Access
Chapter 7. Market Segmentation 3: by Type of Therapeutic Area Estimates & Trend Analysis
7.1. by Type of Therapeutic Area & Market Share, 2019 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Type of Therapeutic Area:
7.2.1. Cardiovascular Disorders
7.2.2. Infectious Diseases
7.2.3. Metabolic Disorders
7.2.4. Neurological Disorders
7.2.5. Oncological Disorders
7.2.6. Respiratory Disorders
7.2.7. Other Disorders
Chapter 8. Market Segmentation 4: by Clinical Trial Phase Estimates & Trend Analysis
8.1. by Clinical Trial Phase & Market Share, 2019 & 2031
8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Clinical Trial Phase:
8.2.1. Phase I
8.2.2. Phase II
8.2.3. Phase III
8.2.4. Phase IV
Chapter 9. Market Segmentation 5: by Company Size Estimates & Trend Analysis
9.1. by Company Size Share, 2019 & 2031
9.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Company Size:
9.2.1. Small
9.2.2. Mid-sized
9.2.3. Large
Chapter 10. Market Segmentation 6: by End Users Estimates & Trend Analysis
10.1. by End Users & Market Share, 2019 & 2031
10.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by End Users:
10.2.1. Pharmaceutical and Biotechnology Companies
10.2.2. Academic and Research Institutes
10.2.3. Medical Device Industries
10.2.4. Other
Chapter 11. Virtual Clinical Trials Market Segmentation 7: Regional Estimates & Trend Analysis
11.1. North America
11.1.1. North America Virtual Clinical Trials Market Revenue (US$ Million) Estimates and Forecasts by Mode of Clinical Trial, 2023-2031
11.1.2. North America Virtual Clinical Trials Market Revenue (US$ Million) Estimates and Forecasts by Study Type, 2023-2031
11.1.3. North America Virtual Clinical Trials Market Revenue (US$ Million) Estimates and Forecasts by Type of Therapeutic Area, 2023-2031
11.1.4. North America Virtual Clinical Trials Market Revenue (US$ Million) Estimates and Forecasts by Clinical Trial Phase, 2023-2031
11.1.5. North America Virtual Clinical Trials Market Revenue (US$ Million) Estimates and Forecasts by Company Size, 2023-2031
11.1.6. North America Virtual Clinical Trials Market Revenue (US$ Million) Estimates and Forecasts by End Users, 2023-2031
11.1.7. North America Virtual Clinical Trials Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
11.2. Europe
11.2.1. Europe Virtual Clinical Trials Market Revenue (US$ Million) Estimates and Forecasts by Mode of Clinical Trial, 2023-2031
11.2.2. Europe Virtual Clinical Trials Market Revenue (US$ Million) Estimates and Forecasts by Study Type, 2023-2031
11.2.3. Europe Virtual Clinical Trials Market Revenue (US$ Million) Estimates and Forecasts by Type of Therapeutic Area, 2023-2031
11.2.4. Europe Virtual Clinical Trials Market Revenue (US$ Million) Estimates and Forecasts by Clinical Trial Phase, 2023-2031
11.2.5. Europe Virtual Clinical Trials Market Revenue (US$ Million) Estimates and Forecasts by Company Size, 2023-2031
11.2.6. Europe Virtual Clinical Trials Market Revenue (US$ Million) Estimates and Forecasts by End Users, 2023-2031
11.2.7. Europe Virtual Clinical Trials Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
11.3. Asia Pacific
11.3.1. Asia Pacific Virtual Clinical Trials Market Revenue (US$ Million) Estimates and Forecasts by Mode of Clinical Trial, 2023-2031
11.3.2. Asia Pacific Virtual Clinical Trials Market Revenue (US$ Million) Estimates and Forecasts by Study Type, 2023-2031
11.3.3. Asia Pacific Virtual Clinical Trials Market Revenue (US$ Million) Estimates and Forecasts by Type of Therapeutic Area, 2023-2031
11.3.4. Asia Pacific Virtual Clinical Trials Market Revenue (US$ Million) Estimates and Forecasts by Clinical Trial Phase, 2023-2031
11.3.5. Asia-Pacific Virtual Clinical Trials Market Revenue (US$ Million) Estimates and Forecasts by Company Size, 2023-2031
11.3.6. Asia-Pacific Virtual Clinical Trials Market Revenue (US$ Million) Estimates and Forecasts by End Users, 2023-2031
11.3.7. Asia Pacific Virtual Clinical Trials Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
11.4. Latin America
11.4.1. Latin America Virtual Clinical Trials Market Revenue (US$ Million) Estimates and Forecasts by Mode of Clinical Trial, 2023-2031
11.4.2. Latin America Virtual Clinical Trials Market Revenue (US$ Million) Estimates and Forecasts by Study Type, 2023-2031
11.4.3. Latin America Virtual Clinical Trials Market Revenue (US$ Million) Estimates and Forecasts by Type of Therapeutic Area, 2023-2031
11.4.4. Latin America Virtual Clinical Trials Market Revenue (US$ Million) Estimates and Forecasts by Clinical Trial Phase, 2023-2031
11.4.5. Latin America Virtual Clinical Trials Market Revenue (US$ Million) Estimates and Forecasts by Company Size, 2023-2031
11.4.6. Latin America Virtual Clinical Trials Market Revenue (US$ Million) Estimates and Forecasts by End Users, 2023-2031
11.4.7. Latin America Virtual Clinical Trials Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
11.5. Middle East & Africa
11.5.1. Middle East & Africa Virtual Clinical Trials Market Revenue (US$ Million) Estimates and Forecasts by Mode of Clinical Trial, 2023-2031
11.5.2. Middle East & Africa Virtual Clinical Trials Market Revenue (US$ Million) Estimates and Forecasts by Study Type, 2023-2031
11.5.3. Middle East & Africa Virtual Clinical Trials Market Revenue (US$ Million) Estimates and Type of Therapeutic Area, 2023-2031
11.5.4. Middle East & Africa Virtual Clinical Trials Market Revenue (US$ Million) Estimates and Forecasts by Clinical Trial Phase, 2023-2031
11.5.5. Middle East & Africa Virtual Clinical Trials Market Revenue (US$ Million) Estimates and Forecasts by Company Size, 2023-2031
11.5.6. Middle East & Africa Virtual Clinical Trials Market Revenue (US$ Million) Estimates and Forecasts by End Users, 2023-2031
11.5.7. Middle East & Africa Virtual Clinical Trials Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
Chapter 12. Competitive Landscape
12.1. Major Mergers and Acquisitions/Strategic Alliances
12.2. Company Profiles
12.2.1. Fortrea
12.2.2. IQVIA
12.2.3. KORE Wireless
12.2.4. Labcorp
12.2.5. Medpace
12.2.6. Parexel
12.2.7. PPD
12.2.8. Syneos Health
12.2.9. Signant Health
12.2.10. Veeva
12.2.11. Cambridge Cognition
12.2.12. Medidata Solutions
12.2.13. PanAmerican Clinical Research
12.2.14. Science 37
12.2.15. Other Prominent Players
12.2.15.1. CareShare
12.2.15.2. Clariness
12.2.15.3. Cliniv
12.2.15.4. Clinscience
12.2.15.5. CMIC
12.2.15.6. DynamiQ Health
12.2.15.7. Emovis
12.2.15.8. Ergomed
12.2.15.9. Flatworld Solutions
12.2.15.10. Gsap
12.2.15.11. Hexaware Technologies
12.2.15.12. Huma
12.2.15.13. ICON
12.2.15.14. Kayentis
12.2.15.15. Tata Consultancy Services
12.2.15.16. Viedoc
12.2.15.17. WeGuide
12.2.15.18. Wren Healthcare
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們